Cargando…
Addendum: The value of comprehensive genomic sequencing to maximize the identification of clinically actionable alterations in advanced cancer patients: a case series
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584422/ https://www.ncbi.nlm.nih.gov/pubmed/36289011 http://dx.doi.org/10.18632/oncotarget.28294 |
| _version_ | 1784813261470826496 |
|---|---|
| author | Drenner, Kevin Basu, Gargi D. Goodman, Laurie J. Ozols, Audrey A. LoBello, Janine R. Royce, Thomas Gordon, Michael S. Borazanci, Erkut H. Steinbach, Margaux A. Trent, Jeffrey Sharma, Sunil |
| author_facet | Drenner, Kevin Basu, Gargi D. Goodman, Laurie J. Ozols, Audrey A. LoBello, Janine R. Royce, Thomas Gordon, Michael S. Borazanci, Erkut H. Steinbach, Margaux A. Trent, Jeffrey Sharma, Sunil |
| author_sort | Drenner, Kevin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9584422 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95844222022-10-21 Addendum: The value of comprehensive genomic sequencing to maximize the identification of clinically actionable alterations in advanced cancer patients: a case series Drenner, Kevin Basu, Gargi D. Goodman, Laurie J. Ozols, Audrey A. LoBello, Janine R. Royce, Thomas Gordon, Michael S. Borazanci, Erkut H. Steinbach, Margaux A. Trent, Jeffrey Sharma, Sunil Oncotarget Addendum Impact Journals LLC 2022-10-20 /pmc/articles/PMC9584422/ /pubmed/36289011 http://dx.doi.org/10.18632/oncotarget.28294 Text en Copyright: © 2022 Drenner et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Addendum Drenner, Kevin Basu, Gargi D. Goodman, Laurie J. Ozols, Audrey A. LoBello, Janine R. Royce, Thomas Gordon, Michael S. Borazanci, Erkut H. Steinbach, Margaux A. Trent, Jeffrey Sharma, Sunil Addendum: The value of comprehensive genomic sequencing to maximize the identification of clinically actionable alterations in advanced cancer patients: a case series |
| title | Addendum: The value of comprehensive genomic sequencing to maximize the identification of clinically actionable alterations in advanced cancer patients: a case series |
| title_full | Addendum: The value of comprehensive genomic sequencing to maximize the identification of clinically actionable alterations in advanced cancer patients: a case series |
| title_fullStr | Addendum: The value of comprehensive genomic sequencing to maximize the identification of clinically actionable alterations in advanced cancer patients: a case series |
| title_full_unstemmed | Addendum: The value of comprehensive genomic sequencing to maximize the identification of clinically actionable alterations in advanced cancer patients: a case series |
| title_short | Addendum: The value of comprehensive genomic sequencing to maximize the identification of clinically actionable alterations in advanced cancer patients: a case series |
| title_sort | addendum: the value of comprehensive genomic sequencing to maximize the identification of clinically actionable alterations in advanced cancer patients: a case series |
| topic | Addendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584422/ https://www.ncbi.nlm.nih.gov/pubmed/36289011 http://dx.doi.org/10.18632/oncotarget.28294 |
| work_keys_str_mv | AT drennerkevin addendumthevalueofcomprehensivegenomicsequencingtomaximizetheidentificationofclinicallyactionablealterationsinadvancedcancerpatientsacaseseries AT basugargid addendumthevalueofcomprehensivegenomicsequencingtomaximizetheidentificationofclinicallyactionablealterationsinadvancedcancerpatientsacaseseries AT goodmanlauriej addendumthevalueofcomprehensivegenomicsequencingtomaximizetheidentificationofclinicallyactionablealterationsinadvancedcancerpatientsacaseseries AT ozolsaudreya addendumthevalueofcomprehensivegenomicsequencingtomaximizetheidentificationofclinicallyactionablealterationsinadvancedcancerpatientsacaseseries AT lobellojaniner addendumthevalueofcomprehensivegenomicsequencingtomaximizetheidentificationofclinicallyactionablealterationsinadvancedcancerpatientsacaseseries AT roycethomas addendumthevalueofcomprehensivegenomicsequencingtomaximizetheidentificationofclinicallyactionablealterationsinadvancedcancerpatientsacaseseries AT gordonmichaels addendumthevalueofcomprehensivegenomicsequencingtomaximizetheidentificationofclinicallyactionablealterationsinadvancedcancerpatientsacaseseries AT borazancierkuth addendumthevalueofcomprehensivegenomicsequencingtomaximizetheidentificationofclinicallyactionablealterationsinadvancedcancerpatientsacaseseries AT steinbachmargauxa addendumthevalueofcomprehensivegenomicsequencingtomaximizetheidentificationofclinicallyactionablealterationsinadvancedcancerpatientsacaseseries AT trentjeffrey addendumthevalueofcomprehensivegenomicsequencingtomaximizetheidentificationofclinicallyactionablealterationsinadvancedcancerpatientsacaseseries AT sharmasunil addendumthevalueofcomprehensivegenomicsequencingtomaximizetheidentificationofclinicallyactionablealterationsinadvancedcancerpatientsacaseseries |